Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Submitted by
admin
on December 4, 2013 - 3:43pm
Source:
Yahoo/AP
News Tags:
Immunomedics
IMMU-132
orphan drugs
small cell lung cancer
Headline:
Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Do Not Allow Advertisers to Use My Personal information
